Product
Lutikizumab
Aliases
ABT-981, Lutikizumab Dose A, Lutikizumab Dose B, Lutikizumab Matching Placebo
4 clinical trials
3 indications
Indication
Healthy Control ParticipantsIndication
Hidradenitis SuppurativaIndication
ulcerative colitisClinical trial
A Phase 1 Study in Healthy Subjects to Evaluate the Relative Bioavailability of Two Lutikizumab Formulations and to Evaluate Lutikizumab Pharmacokinetics, Safety, and Tolerability in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2024-02-26
Clinical trial
A Phase 2 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of Lutikizumab (ABT-981) in Adult Subjects With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy: Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic TherapyStatus: Recruiting, Estimated PCD: 2026-01-24
Clinical trial
A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2027-04-23
Clinical trial
A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects With Moderate to Severe Hidradenitis SuppurativaStatus: Not yet recruiting, Estimated PCD: 2026-12-14